Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of extracorporeal photopheresis with UVADEX for moderate to severe chronic graft-versus-host disease
2010-022780-35Phase 2Completed
- Sponsor
- Therakos
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methoxsalen in chronic graft-versus-host disease (cGVHD) (2 arms), sponsored by Therakos. Primary endpoint: Week 28 overall response. Started Apr 2011; status: completed.
02
Drugs
methoxsalen
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on 2010-022780-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022780-35.